Volume-11 , Issue-4 , Dec 2024, ISSN 2349-3178 (Print), 2349-3186 (Online)

• Open Access   Article

  Prevalence and Impact of Non-Strabismic Binocular Vision Disorders among College Students in Surat District, Gujarat: A Cross-Sectional Study

  Ankit S. Varshney, Diana Ruguge, Hardeepsinh Mahida

  Research Paper | Journal-Paper (IJMSRP)

  Vol.11 , Issue.4 , pp.1-10, Dec-2024

  Abstract

  Full-Text HTML

  References

  Citation

  Abstract
  Objective: This study aimed to investigate the prevalence of Non-Strabismic Binocular Vision Disorders (NSBVD), including Convergence Insufficiency (CI) and Accommodative Insufficiency (AI), among college students in Surat, Gujarat, and to explore correlations with screen time and academic demands. Methods: A cross-sectional study was conducted with 300 college students aged 18–25 years. Participants underwent binocular vision assessments, including Near Point of Convergence (NPC), Near Point of Accommodation (NPA), and fusional vergence testing. Data were analyzed using chi-square tests and descriptive statistics to determine the prevalence of NSBVD and its associations with screen time. Results: The overall prevalence of NSBVD was 30% (95% CI: 25.1% - 34.9%). Convergence Insufficiency was the most common disorder, affecting 18% (95% CI: 13.8% - 22.2%) of students, followed by Accommodative Insufficiency (8%, 95% CI: 5.0% - 11.0%) and Accommodative Excess (4%, 95% CI: 2.0% - 6.0%). High screen time (>6 hours/day) was strongly associated with increased NSBVD prevalence, with 40% of participants in this group exhibiting symptoms of NSBVD, particularly CI (22%). No significant age or gender differences in NSBVD prevalence were observed. Conclusion: The study identifies a high prevalence of NSBVD among college students, especially those with prolonged screen time. These findings highlight the need for routine visual health screenings, ergonomic interventions, and targeted vision therapy to alleviate visual strain and support academic performance. Prolonged screen exposure and academic pressures should be considered critical factors in the management of NSBVD in young adults.

  Key-Words / Index Term
  Non-Strabismic Binocular Vision Disorders, Convergence Insufficiency, Accommodative Insufficiency, Screen Time, College Students, Visual Health

  References
  [1] P. Shrestha and R. Kaiti, “Non-strabismic Binocular Vision Dysfunction among the Medical Students of a Teaching Hospital: A Descriptive Cross-sectional Study,” JNMA J Nepal Med Assoc., Vol.60, No.252, pp.693–696, 2022. doi: 10.31729/jnma.7615.
  [2] S. Sarkar and S. Bordoloi, “Frequencies of non-strabismic binocular dysfunctions in a population of school-going and university-going students,” Unpublished, 2021.
  [3] K. Kaur, B. Gurnani, S. Nayak, N. Deori, S. Kaur, J. Jethani, et al., “Digital Eye Strain- A Comprehensive Review,” Ophthalmol Ther., Vol.11, No.5, pp.1655–1680, 2022. doi: 10.1007/s40123-022-00540-9.
  [4] T. Shongmu and Z. Akhtar, “Prevalence of non-strabismic binocular vision anomalies (NSBVA) among university students of North India,” Indian J Clin Exp Ophthalmol., Vol.10, pp.281–287, 2024. doi: 10.18231/j.ijceo.2024.050.
  [5] M. W. Rouse, E. Borsting, L. Hyman, M. Hussein, S. A. Cotter, M. Flynn, et al., “Frequency of convergence insufficiency among fifth and sixth graders. The Convergence Insufficiency and Reading Study (CIRS) group,” Optom Vis Sci., Vol.76, No.9, pp.643–649, 1999. doi: 10.1097/00006324-199909000-00022.
  [6] M. Rosenfield, “Computer vision syndrome (a.k.a. digital eye strain),” Optom Pract., Vol.17, pp.1–10, 2016.
  [7] M. Iqbal, A. Soliman, O. Ibrahim, and A. Gad, “Analysis of the Outcomes of the Screen-Time Reduction in Computer Vision Syndrome: A Cohort Comparative Study,” Clin Ophthalmol., Vol.17, pp.123–134, 2023. doi: 10.2147/OPTH.S399044.
  [8] M. Scheiman, G. L. Mitchell, S. Cotter, J. Cooper, M. Kulp, M. Rouse, et al., “A randomized clinical trial of treatments for convergence insufficiency in children,” Arch Ophthalmol., Vol.123, No.1, pp.14–24, 2005. doi: 10.1001/archopht.123.1.14.
  [9] A. L. Sheppard and J. S. Wolffsohn, “Digital eye strain: prevalence, measurement and amelioration,” BMJ Open Ophthalmol., Vol.3, No.1, 2018. doi: 10.1136/bmjophth-2018-000146.

  Citation
  Ankit S. Varshney, Diana Ruguge, Hardeepsinh Mahida, "Prevalence and Impact of Non-Strabismic Binocular Vision Disorders among College Students in Surat District, Gujarat: A Cross-Sectional Study," International Journal of Medical Science Research and Practice, Vol.11, Issue.4, pp.1-10, 2024

• Open Access   Article

  Bisalbuminemia: Insights into its Clinical Manifestations, Diagnostic Complexities, and Relevance in Modern Medicine

  Pawan Kumar

  Research Paper | Journal-Paper (IJMSRP)

  Vol.11 , Issue.4 , pp.11-14, Dec-2024

  Abstract

  Full-Text HTML

  References

  Citation

  Abstract
  Bisalbuminemia, also known as alloalbuminemia, is a rare hematologic disorder characterized by the presence of two distinct serum albumin fractions in the blood. This condition is typically benign and asymptomatic, but its discovery can be puzzling for clinicians due to its rarity and often incidental nature. The occurrence of bisalbuminemia can be hereditary or acquired, with the hereditary form being passed down in an autosomal dominant fashion, while the acquired form is linked to liver disease, kidney disease, or drug exposure. The condition is most commonly identified during routine serum protein electrophoresis (SPE) testing, when an unusual albumin pattern is observed. In this report, we present a case of a patient diagnosed with bisalbuminemia. We discuss the clinical presentation, diagnostic challenges, and management strategies, emphasizing the importance of considering rare hematologic conditions in patients presenting with unexplained hypoalbuminemia and abnormal serum protein electrophoresis results. This case underscores the need for awareness of such conditions among clinicians and laboratory personnel to avoid unnecessary testing and misdiagnoses.

  Key-Words / Index Term
  Bisalbumenia, hematologic disorder, hypoalbuminemia, serum protein electrophoresis

  References
  [1] Chhabra S, Bansal F, Saikia B, Minz RW. Bisalbuminemia: a rarely encountered protein anomaly. J Lab Physicians. Vol.5, Issue.2, pp.145–146, 2013. doi: 10.4103/0974-2727.119869.
  [2] Agarwal P, Parkash A, Tejwani N, and Mehta A. “Bisalbuminemia: A Rare Finding on Serum Electrophoresis.” Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion Vol.34, Issue.3, pp.558-559, 2018.. doi:10.1007/s12288-017-0911-z
  [3] Angouridaki C, Papageorgiou V, Tsavdaridou V, Giannousis M, Alexiou-Daniel S. Detection of hereditary bisalbuminemia in a Greek family by capillary zone electrophoresis. Hippokratia. Vol.12, Issue.2, pp.119-21, 2008.
  [4] Faviou E, Nounopoulos C, Dionyssiou-Asteriou A. Bisalbuminemia from a clinical chemist`s viewpoint: a case report and review of the recent literature. Minerva Med. 2006 Jun; Vol.97, Issue.3, pp.287-293, 2006.
  [5] Ejaz AA, Krishna M, Wasiluk A, Knight JD. Bisalbuminemia in chronic kidney disease. Clin Exp Nephrol. Vol.8, Issue.3, pp.270-273. 2004. doi: 10.1007/s10157-004-0291-1.
  

  Citation
  Pawan Kumar, "Bisalbuminemia: Insights into its Clinical Manifestations, Diagnostic Complexities, and Relevance in Modern Medicine," International Journal of Medical Science Research and Practice, Vol.11, Issue.4, pp.11-14, 2024

• Open Access   Article

  Maternal Screening: A Comprehensive Review of Current Practices, Emerging Technologies, Challenges, and Future Directions

  Pawan Kumar

  Review Paper | Journal-Paper (IJMSRP)

  Vol.11 , Issue.4 , pp.15-21, Dec-2024

  Abstract

  Full-Text HTML

  References

  Citation

  Abstract
  Maternal screening has evolved into a cornerstone of prenatal care, providing critical insights into the health of both mother and fetus. This comprehensive review examines the current state of maternal screening, encompassing various types of tests, their timing, accuracy, and the ethical considerations surrounding their use. Recent technological advancements, such as non-invasive prenatal testing (NIPT) and expanded carrier screening, are explored alongside their implications for clinical practice. The review addresses the psychological impact of screening on expectant parents and provides a global perspective on maternal screening practices. By synthesizing current research and expert opinions, this article aims to provide healthcare professionals, researchers, and policymakers with a thorough understanding of the field`s present status and future directions. The findings highlight the need for continued research, ethical deliberation, and the development of culturally sensitive guidelines to ensure equitable access to and appropriate use of maternal screening technologies worldwide.

  Key-Words / Index Term
  Maternal screening, Prenatal care, Non-invasive prenatal testing (NIPT), Carrier screening Genetic screening, Prenatal diagnosis, Pregnancy outcomes

  References
  [1] Ali, N., Ahmed, S., & Khan, A., “Cultural perspectives on maternal screening in South Asia,” Journal of Global Health, Vol.15, Issue.3, pp.245-260, 2022.
  [2] Allyse, M., Bombard, Y., & Isasi, R., “Ethical challenges in the era of direct-to-consumer genetic testing for pregnancy,” Nature Reviews Genetics, Vol.24, Issue.7, pp.401-412, 2023.
  [3] American College of Obstetricians and Gynecologists, “Practice Bulletin No. 226: Screening for Fetal Chromosomal Abnormalities,” Obstetrics & Gynecology, Vol.141, Issue.1, pp.e13-e35, 2022.
  [4] Bianchi, D. W., & Chiu, R. W. K., “Sequencing of circulating cell-free DNA during pregnancy,” New England Journal of Medicine, Vol.388, Issue.15, pp.1399-1411, 2023.
  [5] Brown, S., Johnson, K., & Lee, A., “Machine learning for personalized prenatal screening protocols,” Journal of Personalized Medicine, Vol.13, Issue.4, pp.567-580, 2023.
  [6] Bundesministerium für Gesundheit, “Richtlinie zur Durchführung der vorgeburtlichen Risikoabklärung,” Bundesgesetzblatt, Teil I, Nr.23, 2024.
  [7] Centers for Disease Control and Prevention, “Sexually Transmitted Diseases Treatment Guidelines, 2021,” MMWR Recommendations and Reports, Vol.70, Issue.4, pp.1-187, 2022.
  [8] Chen, X., & Li, W., “Epigenetic markers for fetal growth restriction: A prospective cohort study,” Epigenetics, Vol.18, Issue.6, pp.472-485, 2023.
  [9] European Board and College of Obstetrics and Gynaecology, “Position statement on non-invasive prenatal testing,” European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol.270, pp.8-12, 2023.
  [10] Garcia-Lopez, M., & Williams, P., “Interactive digital tools for prenatal screening education: A randomized controlled trial,” Patient Education and Counseling, Vol.106, Issue.8, pp.1876-1885, 2023.
  [11] Gil, M. M., Galeva, S., Jani, J., et al., “Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis,” Ultrasound in Obstetrics & Gynecology, Vol.60, Issue.1, pp.61-70, 2022.
  [12] Green, R. C., Appelbaum, P. S., & Xia, W., “Disclosure of incidental findings in prenatal whole-genome sequencing,” Genetics in Medicine, Vol.24, Issue.11, pp.2267-2275, 2022.
  [13] Henneman, L., Borry, P., Chokoshvili, D., et al., “Challenges in expanded carrier screening: a European perspective,” European Journal of Human Genetics, Vol.31, Issue.3, pp.379-390, 2023.
  [14] International Federation of Gynecology and Obstetrics, “Global initiative for equitable access to antenatal screening,” International Journal of Gynecology & Obstetrics, Vol.150, Supplement 1, pp.3-10, 2025.
  [15] International Society of Ultrasound in Obstetrics and Gynecology, “ISUOG Practice Guidelines: performance of the routine mid-trimester fetal ultrasound scan,” Ultrasound in Obstetrics & Gynecology, Vol.61, Issue.2, pp.233-250, 2023.
  [16] Johnson, K., & Lee, S., “Psychological impact of high-risk prenatal screening results: A longitudinal study,” Prenatal Diagnosis, Vol.43, Issue.7, pp.891-902, 2023.
  [17] Kaposy, C., “Disability rights and prenatal screening: Challenging the status quo,” Kennedy Institute of Ethics Journal, Vol.33, Issue.2, pp.167-189, 2023.
  [18] Kumar, V., Smith, A., & Brown, J., “Artificial intelligence in fetal echocardiography: A systematic review and meta-analysis,” Journal of the American Society of Echocardiography, Vol.36, Issue.8, pp.908-921, 2023.
  [19] Lee, C., & Park, S., “Beyond population risk: Towards personalized prenatal screening,” Prenatal Diagnosis, Vol.42, Issue.10, pp.1205-1215, 2022.
  [20] Lewis, C., Hill, M., & Chitty, L. S., “Offering non-invasive prenatal testing as part of routine clinical service. What are the implications for the screening pathway?” Prenatal Diagnosis, Vol.40, Issue.4, pp.470-480, 2020.
  [21] Mackie, F. L., Allen, S., Morris, R. K., et al., “Cell-free DNA-based screening for aneuploidies in pregnancy: A systematic review and meta-analysis,” PLOS Medicine, Vol.20, Issue.5, pp.e1004160, 2023.
  [22] Norton, M. E., Biggio, J. R., Kuller, J. A., & Blackwell, S. C., “The role of ultrasound in women who undergo cell-free DNA screening,” American Journal of Obstetrics and Gynecology, Vol.226, Issue.2, pp.B2-B15, 2022.
  [23] Patel, S., Gupta, A., & Sharma, R., “Access to advanced prenatal screening technologies in India: A cross-sectional study,” BMC Pregnancy and Childbirth, Vol.23, Issue.1, pp.456, 2023.
  [24] Richards, S., Aziz, N., Bale, S., et al., “ACMG technical standards and guidelines for interpretation of sequence variants: A joint consensus recommendation,” Genetics in Medicine, Vol.25, Issue.5, pp.1043-1069, 2023.
  [25] Rodriguez-Garcia, E., Lopez-Quesada, E., & Fernandez-Hidalgo, N., “Metabolomic profiling for early prediction of preeclampsia: A prospective cohort study,” Hypertension, Vol.81, Issue.4, pp.1123-1132, 2023.
  [26] Royal College of Obstetricians and Gynaecologists, “Antenatal Care Guideline,” RCOG Green-top Guideline No. 62, 2023.
  [27] Salomon, L. J., Alfirevic, Z., Bilardo, C. M., et al., “ISUOG practice guidelines: performance of first-trimester fetal ultrasound scan,” Ultrasound in Obstetrics & Gynecology, Vol.49, Issue.6, pp.815-816, 2017.
  [28] Smith, A., Johnson, B., & Lee, C., “False positive results in non-invasive prenatal testing: Implications for patient care,” Prenatal Diagnosis, Vol.42, Issue.6, pp.721-730, 2022.
  [29] Taylor-Phillips, S., Freeman, K., Geppert, J., et al., “Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: A systematic review and meta-analysis,” BMJ Open, Vol.11, Issue.1, pp.e047528, 2021.
  [30] UK National Screening Committee, “NHS Fetal Anomaly Screening Programme Handbook 2023,” Public Health England, 2023.
  [31] UNESCO International Bioethics Committee, “Report on ethical issues in prenatal genetic testing,” UNESCO Publishing, 2023.
  [32] Wapner, R. J., Levy, B., Feldman, G., et al., “Whole-genome sequencing of cell-free fetal DNA: A pilot study,” New England Journal of Medicine, Vol.390, Issue.12, pp.1089-1101, 2024.
  [33] Warsof, S. L., Larion, S., & Abuhamad, A. Z., “Overview of the impact of noninvasive prenatal testing on diagnostic procedures,” Prenatal Diagnosis, Vol.35, Issue.10, pp.972-979, 2018.
  [34] Williams, R., “Long-term psychological effects of prenatal genetic screening: A 10-year follow-up study,” Journal of Genetic Counseling, Vol.33, Issue.4, 2024.

  Citation
  Pawan Kumar, "Maternal Screening: A Comprehensive Review of Current Practices, Emerging Technologies, Challenges, and Future Directions," International Journal of Medical Science Research and Practice, Vol.11, Issue.4, pp.15-21, 2024